These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15062056)

  • 21. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
    Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer.
    Sagara Y; Mimori K; Yoshinaga K; Tanaka F; Nishida K; Ohno S; Inoue H; Mori M
    Br J Cancer; 2004 Aug; 91(5):959-65. PubMed ID: 15305200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer.
    Agudo D; Gómez-Esquer F; Martínez-Arribas F; Núñez-Villar MJ; Pollán M; Schneider J
    Int J Cancer; 2004 May; 109(5):717-20. PubMed ID: 14999780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression and clinical significance of KNSL4 in breast cancer].
    Feng YM; Wan YF; Li XQ; Cao XC; Li X
    Ai Zheng; 2006 Jun; 25(6):744-8. PubMed ID: 16764773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Abnormal expression of RSK-4 and its clinical significance in breast cancer].
    Liu JL; Yang HW; Chen ZS; Jiang Y
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):452-6. PubMed ID: 21875487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of KLK6 protein and mRNA in primary breast cancer and its clinical significance].
    Wang SM; Mao J; Li B; Wu W; Tang LL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1087-9. PubMed ID: 18992199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk.
    Katz E; Dubois-Marshall S; Sims AH; Faratian D; Li J; Smith ES; Quinn JA; Edward M; Meehan RR; Evans EE; Langdon SP; Harrison DJ
    Br J Cancer; 2010 Jul; 103(3):401-10. PubMed ID: 20628393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.
    Stark AM; Tongers K; Maass N; Mehdorn HM; Held-Feindt J
    J Cancer Res Clin Oncol; 2005 Mar; 131(3):191-8. PubMed ID: 15592684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.
    Wang L; Devarajan E; He J; Reddy SP; Dai JL
    Cancer Res; 2005 Nov; 65(22):10289-97. PubMed ID: 16288017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
    Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
    Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
    Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and methylation status of the Syk gene in cervical carcinoma.
    Zhao S; Sun G; Tony PW; Ma D; Zhao C
    Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of membrane type-1 matrix metalloproteinase expression in breast cancer].
    Yao GY; Yang MT; Rong TH; He P
    Ai Zheng; 2004 Nov; 23(11 Suppl):1482-6. PubMed ID: 15566663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.
    Tong D; Schneeberger C; Czerwenka K; Schmutzler RK; Speiser P; Kucera E; Concin N; Kubista E; Leodolter S; Zeillinger R
    Clin Cancer Res; 1999 Jun; 5(6):1497-502. PubMed ID: 10389938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of SM22α and its relationship with lymph node metastasis in breast cancer].
    MA ZF; CUI NP; SHI JH; WANG HY; SHI SH; WEN M; LI Z
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(36):2545-8. PubMed ID: 21092460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.
    Zhang X; Zhang Y; Yang Y; Niu M; Sun S; Ji H; Ma Y; Yao G; Jiang Y; Shan M; Zhang G; Pang D
    Cancer Epidemiol; 2012 Jun; 36(3):288-93. PubMed ID: 21889920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
    Coebergh van den Braak RRJ; Sieuwerts AM; Kandimalla R; Lalmahomed ZS; Bril SI; van Galen A; Smid M; Biermann K; van Krieken JHJM; Kloosterman WP; Foekens JA; Goel A; Martens JWM; IJzermans JNM;
    PLoS One; 2017; 12(9):e0185607. PubMed ID: 28957395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.